November 21, 2024
Interest is growing in the role of nutrition as means of slowing, or even preventing, neurodegeneration in patients with Parkinson’s disease (PD). For 15 years, John […]
November 21, 2024
It was 1996, and Masashi Yanagisawa was on the brink of his next discovery. The Japanese scientist had arrived at the University of Texas Southwestern 5 […]
November 21, 2024
Nonarteritic anterior ischemic optic neuropathy (NAION) is significantly associated with persistently elevated risk for stroke, independent of typical cardiovascular risk factors, a large multinational cohort study […]
November 20, 2024
TOPLINE: Sleep-related daytime dysfunction is associated with an almost threefold higher risk for motoric cognitive risk (MCR) syndrome, a predementia condition characterized by slow gait and […]
November 19, 2024
The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency. The gene […]
November 15, 2024
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Leqembi (lecanemab) to treat mild cognitive impairment […]
November 15, 2024
Signs of frailty may signal future dementia more than a decade before cognitive symptoms occur, in new findings that may provide a potential opportunity to identify […]
November 14, 2024
The European Society of Cardiology (ESC) caused a stir when they recommended in their latest atrial fibrillation (AF) management guideline that gender no longer be included […]
November 14, 2024
Persistent prenatal distress is associated with a significantly increased risk for epilepsy in offspring, a new study showed. Investigators emphasized that the risk was only slightly […]